Document detail
ID

oai:pubmedcentral.nih.gov:1033...

Topic
Research
Author
Woo, Hyeong-Taek Jeong, Seung-Yong Shin, Aesun
Langue
en
Editor

BioMed Central

Category

BMC Cancer

Year

2023

listing date

12/4/2023

Keywords
classified prognosis effect patients level atc study colorectal cancer
Metrics

Abstract

BACKGROUND: With the availability of health insurance claim data, pharmacovigilance for various drugs has been suggested; however, it is necessary to establish an appropriate analysis method.

To detect unintended drug effects and to generate new hypotheses, we conducted a hypothesis-free study to systematically examine the relationship between all prescription nonanticancer drugs and the mortality of colorectal cancer patients.

METHODS: We used the Korean National Health Insurance Service-National Sample Cohort database.

A total of 2,618 colorectal cancer patients diagnosed between 2004 and 2015 were divided into drug discovery and drug validation sets (1:1) through random sampling.

Drugs were classified using the Anatomical Therapeutic Chemical (ATC) classification system: 76 drugs classified as ATC level 2 and 332 drugs classified as ATC level 4 were included in the analysis.

We used a Cox proportional hazard model adjusted for sex, age, colorectal cancer treatment, and comorbidities.

The relationship between all prescription nonanticancer drugs and the mortality of colorectal cancer patients was analyzed, controlling for multiple comparisons with the false discovery rate.

RESULTS: We found that one ATC level-2 drug (drugs that act on the nervous system, including parasympathomimetics, addictive disorder drugs, and antivertigo drugs) showed a protective effect related to colorectal cancer prognosis.

At the ATC level 4 classification, 4 drugs were significant: two had a protective effect (anticholinesterases and opioid anesthetics), and the other two had a detrimental effect (magnesium compounds and Pregnen [4] derivatives).

CONCLUSIONS: In this hypothesis-free study, we identified four drugs linked to colorectal cancer prognosis.

The MWAS method can be useful in real-world data analysis.

SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-11105-9.

Woo, Hyeong-Taek,Jeong, Seung-Yong,Shin, Aesun, 2023, The association between prescription drugs and colorectal cancer prognosis: a nationwide cohort study using a medication-wide association study, BioMed Central

Document

Open Open

Share

Source

Articles recommended by ES/IODE AI

Exploration of the influence of GOLGA8B on prostate cancer progression and the resistance of castration-resistant prostate cancer to cabazitaxel
castration-resistant prostate canc... ... cabazitaxel cancer development expression genes influence crpc resistance golga8b pca prostate cancer cabazitaxel